Other European Operations
Otsuka Map
Otsuka Pharmaceutical Europe Ltd. (OPEL) has established businesses in many European markets, shown on the map above. In our other European countries*, Otsuka’s European operation supplies its medicines through a combination of collaborations and distributors. *Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Iceland, Ireland, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia and Slovenia. In addition, Otsuka Novel Products GmbH in Munich, Germany (Marketing Authorisation Holder) is working on commercial and public health strategies to improve TB care and ensure rational use of new anti-TB medications.

Otsuka's Global TB Programme


Otsuka Pharmaceutical Company’s (OPC) global tuberculosis programme exemplifies the company’s creative ingenuity and patient-centred approach. We have worked relentlessly for more than 40 years to find a treatment option for patients suffering from multidrug-resistant tuberculosis (MDR-TB). Remaining focused on this dream, European regulatory approval for a novel compound was granted in April 2014.